{"product_id":"retatrutide-10mg-triple-agonist-metabolic-peptide-advanced-metabolic-research","title":"Retatrutide 10mg Triple-Agonist Metabolic Peptide | Advanced Metabolic Research","description":"\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eRetatrutide 10mg\u003c\/strong\u003e \u003cem\u003eTriple-Agonist Metabolic Peptide | Advanced Metabolic Research\u003c\/em\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e Retatrutide is a next-generation synthetic peptide engineered as a \u003cstrong\u003etriple receptor agonist\u003c\/strong\u003e, simultaneously targeting the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. The 10mg presentation is developed for advanced research into metabolic regulation, energy expenditure, and adipose tissue biology — positioned at the cutting edge of incretin-class peptide science.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eMechanism of Interest\u003c\/strong\u003e Retatrutide represents the evolution of incretin research beyond single- and dual-agonist models (such as semaglutide and tirzepatide). By engaging three distinct metabolic receptors in concert, it has become a focal point in research investigating energy balance, lipolysis, glucose handling, hepatic metabolism, and central appetite regulation. The triple-agonist profile is of particular interest in studies exploring synergistic effects on body composition, metabolic flexibility, and obesity-related pathways.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eProduct Specifications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul class=\"[li_\u0026amp;]:mb-0 [li_\u0026amp;]:mt-1 [li_\u0026amp;]:gap-1 [\u0026amp;:not(:last-child)_ul]:pb-1 [\u0026amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\"\u003e\n\u003cli class=\"whitespace-normal break-words pl-2\"\u003eProduct Name: Retatrutide 10mg\u003c\/li\u003e\n\u003cli class=\"whitespace-normal break-words pl-2\"\u003eCatalogue Reference: RETA10-024\u003c\/li\u003e\n\u003cli class=\"whitespace-normal break-words pl-2\"\u003eClass: GLP-1 \/ GIP \/ Glucagon Triple Agonist\u003c\/li\u003e\n\u003cli class=\"whitespace-normal break-words pl-2\"\u003ePurity: ≥98% (HPLC verified)\u003c\/li\u003e\n\u003cli class=\"whitespace-normal break-words pl-2\"\u003ePresentation: Lyophilised solid\u003c\/li\u003e\n\u003cli class=\"whitespace-normal break-words pl-2\"\u003eStorage: -20°C\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eResearch Applications\u003c\/strong\u003e Retatrutide is utilised across metabolic, endocrinology, and obesity research — particularly in studies investigating adiposity reduction, insulin sensitivity, hepatic lipid metabolism, energy expenditure, appetite signalling, and cardiometabolic markers. Its triple-receptor engagement makes it one of the most advanced research tools available for investigating multi-pathway metabolic modulation.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eComparative Research Context\u003c\/strong\u003e Retatrutide is frequently studied alongside semaglutide (GLP-1 mono-agonist) and tirzepatide (GLP-1\/GIP dual-agonist) in comparative research models, where its additional glucagon receptor activity is explored as a contributor to enhanced energy expenditure and hepatic effects — distinguishing it from earlier-generation incretin peptides.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eQuality \u0026amp; Handling\u003c\/strong\u003e Synthesised under controlled laboratory conditions and supplied as a lyophilised solid for maximum stability. Reconstitution with appropriate bacteriostatic solution is required prior to use in any research model. Every batch is subjected to rigorous quality control to ensure purity, structural integrity, and batch-to-batch consistency.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eCompliance Statement\u003c\/strong\u003e All Asclepius peptide products are supplied \u003cstrong\u003estrictly for laboratory research purposes\u003c\/strong\u003e. They are not intended for human consumption, diagnosis, treatment, or therapeutic use. Enquiries relating to human application cannot be supported.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eOrder with Confidence\u003c\/strong\u003e Asclepius peptides are sourced, tested, and dispatched to a clinical standard — built for researchers and practitioners who refuse to compromise on integrity, purity, or precision.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eFor technical specifications, certificates of analysis, or research support, our team is available to assist.\u003c\/p\u003e","brand":"Asclepius Peptides","offers":[{"title":"Default Title","offer_id":53453597081942,"sku":null,"price":219.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0981\/6843\/9126\/files\/rn-image_picker_lib_temp_e32617ff-148e-457b-8f0a-f67691b9c623.png?v=1778053240","url":"https:\/\/asclepiuspeptides.co.uk\/products\/retatrutide-10mg-triple-agonist-metabolic-peptide-advanced-metabolic-research","provider":"Asclepius Peptides","version":"1.0","type":"link"}